FDA•LOW
Eptifibatide Injection 75 mg/100 mL
Slate Run Pharmaceuticals recalls Eptifibatide Injection 75 mg/100 mL vials (NDC 70436-027-80, 70436-163-80) due to incorrect dosing-route labeling.
Filters
Category
Agency
Severity
Date
Distributed in
All Recalls
Back to home ←
FDA•LOWSodexo Stars Saccharin Pink PacketsSodexo Stars Saccharin (Pink) packets are recalled due to undeclared aspartame, which may pose a risk to individuals with PKU.
FDA•LOWDoxazosin Tablets, USP 4 mgUnichem is recalling Doxazosin Tablets 4 mg (NDC 29300-353-10) due to incorrect tablet imprinting that may cause medication errors.
FDA•LOWStraumann WB Impression Post Closed TrayStraumann is recalling WB Impression Post Closed Tray kits (L 13mm) due to incorrect magenta impression caps instead of brown.